NewHavenBIZ

n e w h a v e n b i z . c o m | F e b r u a r y 2 0 2 1 | n e w h a v e n B I Z 19 P o w e r 2 5 M arna Borgstrom has overseen the state's largest health system through the greatest health cri- sis in the last century. As CEO of Yale New Haven Health, she manages not only Yale New Haven Hospital, but Bridgeport Hospital, Greenwich Hospital, Lawrence+Me- morial Hospital in New London and Westerly Hospital in Rhode Island. Borgstrom began her career at Yale New Haven Hospital more than four decades ago, rising to her current position in 2005. During the crisis, Borgstrom has led staff members as they have cared for thousands of critically ill patients. rough it all, she has worked to make sure the hospitals have enough equipment and have been able to offer increased telehealth services. Borgstrom also has helped the sys- tem navigate the pandemic's negative financial impact — including lost revenue due to some patients delaying care. She has worked to restore non- COVID revenue streams. rough it all, she has frequently expressed her commitment to avoiding layoffs. As CEO, she manages an enterprise with some $5.5 billion in revenue. R eal estate developer Carter Winstanley has a vision for turning New Haven into a well- known life science community, and he has been turning that vision into reality. Winstanley sees the potential for the Elm City, with its universities and hospitals and support for the life science industry, to become a biotech hub. Winstanley has heard biotech companies and Realtors say there is a need for space for these companies to grow, and he has set about addressing that need. Winstanley years ago transformed the former Southern New England Telephone Co. building on George Street into a haven for biotechs. His buildings at 25 Science Park and 100 College St. in New Haven are also bioscience havens. His latest project involves a second, $100 million, 500,000-square-foot bioscience tower at 101 College St., which will be built on top of the existing Route 34 connector. Construction is slated to begin this spring and finish in 2023. It will mean more room to accommodate the bioscience industry, which needs more lab, research and incubator space. e Carter Winstanley, Winstanley Enterprises new bioscience tower is expected to create some 1,000 construction jobs, and between 700 and 1,000 permanent jobs, and would generate some $78 million in wages, the developer told the city during the application process. Tenants will include bioscience companies and the Yale University School of Medicine. Winstanley is in the midst of leasing space with area companies. Another of Winstanley's assets, the Temple Medical Center, will provide some additional lab space in the interim. n Marna Borgstrom, CEO, Yale New Haven Health Borgstrom has also taken on a leadership role beyond the system, meeting regularly with the media during the pandemic to give key updates and recommendations to the public on how to stay safe. Her role has extended to prevention, with Yale New Haven Health officials taking part in vaccine trials, and once vaccines garnered approval, taking a leading role in the ongoing vaccination campaign. n PHOTO | STEVE LASCHEVER PHOTO | STEVE LASCHEVER

• Cover